119 S5237 IS: Stop Superbugs Act U.S. Senate 2026-08-04 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

II119th CONGRESS2d SessionS. 5237IN THE SENATE OF THE UNITED STATESAugust 4, 2026Ms. Hassan (for herself and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and PensionsA BILLTo require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes.

1.

Short title

This Act may be cited as the Stop Superbugs Act.

2.

Funding for antibiotic resistance clinical research

(a)

In general

The Director of the National Institute of Allergy and Infectious Diseases shall award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, which shall include focuses on—(1)supporting rapid recruitment of clinical trial participants;(2)conducting clinical trial recruitment outreach in community settings;(3)supporting the pairing of diagnostic and pharmaceutical innovations during clinical trials; and(4)developing patient-reported outcomes in clinical studies.(b)

Authorization of appropriations

There is authorized to be appropriated to the Director of the National Institute of Allergy and Infectious Diseases such sums as may be necessary to carry out subsection (a).